HKDC1; ALOX15; USP2; | |
KDM4E; | |
SLCO1B3; SLCO1B1; |
Cytochrome P450 Enzymes: | CYP1A2; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Enzyme_unclassified | HKDC1 | Putative hexokinase HKDC1 | Q2TB90 | CHEMBL1741200 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | USP2 | Ubiquitin carboxyl-terminal hydrolase 2 | O75604 | CHEMBL1293227 |
Lysine demethylase | KDM4E | Lysine-specific demethylase 4D-like | B2RXH2 | CHEMBL1293226 |
SLC superfamily of solute carriers | SLCO1B3 | Solute carrier organic anion transporter family member 1B3 | Q9NPD5 | CHEMBL1743121 |
SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0051179; localization | GO:0043252; sodium-independent organic anion transport | 4.236E-05 | 2.653E-01 | SLCO1B1, SLCO1B3 |
BP | GO:0051179; localization | GO:0015721; bile acid and bile salt transport | 4.873E-05 | 2.653E-01 | SLCO1B1, SLCO1B3 |
MF | GO:0005215; transporter activity | GO:0015125; bile acid transmembrane transporter activity | 1.718E-05 | 2.653E-01 | SLCO1B1, SLCO1B3 |
MF | GO:0005215; transporter activity | GO:0015347; sodium-independent organic anion transmembrane transporter activity | 3.095E-05 | 2.653E-01 | SLCO1B1, SLCO1B3 |
MF | GO:0003824; catalytic activity | GO:0032451; demethylase activity | 8.289E-05 | 3.610E-01 | CYP1A2, KDM4E |
BP | GO:0008152; metabolic process | GO:0019369; arachidonic acid metabolic process | 1.597E-04 | 4.346E-01 | ALOX15, CYP1A2 |
BP | GO:0008152; metabolic process | GO:0070988; demethylation | 1.907E-04 | 4.615E-01 | CYP1A2, KDM4E |
BP | GO:0008152; metabolic process | GO:0032787; monocarboxylic acid metabolic process | 4.924E-04 | 7.173E-01 | ALOX15, CYP1A2, HKDC1 |
BP | GO:0008152; metabolic process | GO:2001303; lipoxin A4 biosynthetic process | 7.247E-04 | 7.173E-01 | ALOX15 |
MF | GO:0003824; catalytic activity | GO:0051213; dioxygenase activity | 4.441E-04 | 7.173E-01 | ALOX15, KDM4E |
MF | GO:0003824; catalytic activity | GO:0047977; hepoxilin-epoxide hydrolase activity | 7.247E-04 | 7.173E-01 | ALOX15 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 1.393E-03 | 8.303E-01 | ALOX15, CYP1A2 |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 1.876E-03 | 8.511E-01 | SLCO1B1, SLCO1B3 |
CC | GO:0044464; cell part | GO:0031234; extrinsic component of cytoplasmic side of plasma membrane | 2.581E-02 | 1.000E+00 | ALOX15 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 4.244E-05 | 1.019E-03 | CYP1A2, ALOX15 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 2.580E-04 | 3.095E-03 | SLCO1B1, SLCO1B3 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 6.873E-03 | 3.187E-02 | HKDC1, CYP1A2, ALOX15 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 1.392E-02 | 3.187E-02 | CYP1A2 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 1.045E-02 | 3.187E-02 | HKDC1 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00500 | Starch and sucrose metabolism | 1.944E-02 | 3.187E-02 | HKDC1 |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04930 | Type II diabetes mellitus | 1.668E-02 | 3.187E-02 | HKDC1 |
09150 Organismal Systems | 09154 Digestive system | hsa04973 | Carbohydrate digestion and absorption | 1.565E-02 | 3.187E-02 | HKDC1 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00524 | Butirosin and neomycin biosynthesis | 1.749E-03 | 1.049E-02 | HKDC1 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 1.749E-03 | 1.049E-02 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|